GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1 - 25** of **4050** in total

1

2

3

4

5

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgA	Patient 1	10	moderate	G00048MO	382
IgA	Patient 1	22	moderate	G00048MO	337
IgA	Patient 1	6	moderate	G00048MO	364
IgG	Patient 1	10	moderate	G00048MO	24
IgG	Patient 1	22	moderate	G00048MO	24
IgG	Patient 1	6	moderate	G00048MO	24
IgM	Patient 1	10	moderate	G00048MO	45
IgM	Patient 1	22	moderate	G00048MO	45
IgA	Patient 2	15	mild	G00048MO	304
IgA	Patient 2	24	mild	G00048MO	329
IgG	Patient 2	15	mild	G00048MO	32
IgG	Patient 2	24	mild	G00048MO	33
IgM	Patient 2	15	mild	G00048MO	58
IgM	Patient 2	24	mild	G00048MO	68
IgM	Patient 1	6	moderate	G00048MO	35
IgA	Patient 2	3	mild	G00048MO	295
IgG	Patient 2	3	mild	G00048MO	29
IgM	Patient 2	3	mild	G00048MO	68
IgA	Patient 3	-180	mild	G00048MO	255
IgA	Patient 3	11	mild	G00048MO	388
IgG	Patient 3	-180	mild	G00048MO	40
IgG	Patient 3	11	mild	G00048MO	48
IgM	Patient 3	-180	mild	G00048MO	67
IgA	Patient 3	4	mild	G00048MO	272
IgG	Patient 3	4	mild	G00048MO	43